Monday, September 14, 2026

How JNPMEDI Plans to Achieve 250% Revenue Growth in 2026: A Guide for Pharma Innovators

JNPMEDI aims to enhance its global role in drug and medical device development, achieving significant growth and expanding partnerships.

US Senate Passes NDAA Limiting USFK Reduction, Trump Signature Pending

The U.S. Senate passed the NDAA for FY2026, limiting troop reductions in South Korea and allocating $901 billion for defense.

Trump Slams Bad Bunny’s Spanish-Language Super Bowl LX Halftime Show: The Culture-War Signal Behind the Post

Trump criticized the Super Bowl halftime show in Spanish, sharing a doctored image suggesting U.S. expansion amid Bad Bunny's performance.

Tag: K-Cap

HK inno.N’s New Drug K-CAB Applies for U.S. FDA Approval: How Innovative Is the P-CAB Therapy?

HK inno.N's K-Cap for GERD has entered the U.S. approval process, showing superior results in clinical trials over existing treatments.

Top News

- Our Sponsors Ad -

Follow us